Publication of a Prospectus
Source: RNSNatWest Markets Plc
Publication of Prospectuses
The following prospectuses have been approved by the Financial Conduct Authority and are available for viewing:
Prospectus relating to the NatWest Markets Plc £10,000,000,000 Euro Medium Term Note Programme dated 21 November 2019
Prospectus relating to the NatWest Markets Plc £5,000,000,000 Structured Debt Issuance Programme dated 21 November 2019
To view the full documents, please paste the following URLs into the address bar of your browser, as applicable:
http://www.rns-pdf.londonstockexchange.com/rns/2881U_1-2019-11-21.pdf
http://www.rns-pdf.londonstockexchange.com/rns/2881U_2-2019-11-21.pdf
A copy of each of the above Prospectuses has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.
For further information, please contact:
Anthony Everill
Head of Capital Markets & Funding, NatWest Markets
Tel: +44 (0) 203 361 7679
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in each of the Prospectuses may be addressed to and/or targeted at persons who are residents of particular countries (specified in each of the Prospectuses) only and is not intended for use and should not be relied upon by any person outside of these countries and/or to whom the offer contained in each of the Prospectuses is not addressed. Prior to relying on the information contained in each of the Prospectuses you must ascertain from each of the Prospectuses whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
Legal Entity Identifier: RR3QWICWWIPCS8A4S074
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
